Intellia Therapeutics, Inc. (NTLA)
11.10
-1.21
(-9.83%)
USD |
NASDAQ |
Nov 05, 16:00
11.28
+0.18
(+1.62%)
After-Hours: 06:50
Intellia Therapeutics SG&A Expense (TTM) : 105.74M for Sept. 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 105.74M |
| June 30, 2026 | 136.25M |
| March 31, 2026 | 125.64M |
| December 31, 2025 | 119.80M |
| September 30, 2025 | 119.17M |
| June 30, 2025 | 119.16M |
| March 31, 2025 | 123.74M |
| December 31, 2024 | 125.83M |
| September 30, 2024 | 122.38M |
| June 30, 2024 | 121.28M |
| March 31, 2024 | 120.14M |
| December 31, 2023 | 116.50M |
| September 30, 2023 | 111.13M |
| June 30, 2023 | 103.87M |
| March 31, 2023 | 95.35M |
| December 31, 2022 | 90.31M |
| September 30, 2022 | 88.79M |
| June 30, 2022 | 85.35M |
| March 31, 2022 | 79.90M |
| December 31, 2021 | 71.10M |
| September 30, 2021 | 59.75M |
| June 30, 2021 | 51.61M |
| Date | Value |
|---|---|
| March 31, 2021 | 46.45M |
| December 31, 2020 | 44.17M |
| September 30, 2020 | 42.38M |
| June 30, 2020 | 40.25M |
| March 31, 2020 | 41.84M |
| December 31, 2019 | 41.06M |
| September 30, 2019 | 40.79M |
| June 30, 2019 | 40.63M |
| March 31, 2019 | 35.32M |
| December 31, 2018 | 32.19M |
| September 30, 2018 | 33.69M |
| June 30, 2018 | 31.14M |
| March 31, 2018 | 29.70M |
| December 31, 2017 | 28.02M |
| September 30, 2017 | 22.93M |
| June 30, 2017 | 21.92M |
| March 31, 2017 | 19.28M |
| December 31, 2016 | 16.80M |
| September 30, 2016 | 11.68M |
| June 30, 2016 | 6.975M |
| March 31, 2016 | 3.246M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Twist Bioscience Corp. | 290.29M |
| Beam Therapeutics, Inc. | 98.66M |
| Prime Medicine, Inc. | 54.39M |
| 10X Genomics, Inc. | 297.01M |
| Moderna, Inc. | 965.00M |